Dodick, David W.
https://orcid.org/0000-0002-9486-6790
Mayo Clinic
Atria Academy of Science and Medicine, New York, NY, United States
Citations 387
Clinically Meaningful Benefits of OnabotulinumtoxinA Beyond Headache Days in Chronic Migraine: Analysis of the COMPEL and Pooled PREEMPT Studies (361)
Blumenfeld, Andrew , Diener, Hans‐Christoph, DeGryse, Ronald E., Adams, Aubrey Manack, Silberstein, Stephen D., Diener, Hans‐Christoph, Lipton, Richard B. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Acute Treatment Patterns Among New Triptan Treatment Users and Potential Triptan Insufficient Responders (330)
Shewale, Anand R. , Viswanathan, Hema N., Marcus, Steven C. , Lipton, Richard B. , Dodick, David W. , Doshi, Jalpa A.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366)
Pavlović, Jelena , Tepper, Stewart J. , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Friedman, Deborah I. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials (2091)
Pavlović, Jelena , Stock, Elyse, Thiry, Alexandra, Conway, Charles M., Jensen, Christopher, Morris, Beth , Coric, Vladimir, Croop, Robert , Pavlovic, Jelena M. , Dodick, David W. , Newman, Lawrence C. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Impact of Depression and Anxiety Symptoms on Patient-reported Outcomes in Patients with Migraine: Results from the American Registry for Migraine Research (ARMR) (18)
Pearl, Talia A. , Dumkrieger, Gina , Chong, Catherine D. , Schwedt, Todd J. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Sustained Benefits of OnabotulinumtoxinA Treatment in Chronic Migraine: Results from a PREEMPT Pooled Analysis (1699)
Silberstein, Stephen D., Diener, Hans‐Christoph, Yedigarova, Larisa, Diener, Hans‐Christoph, Dodick, David W. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Ubrogepant Achieves Onset of Pain Relief at 1 Hour for the Acute Treatment of Migraine (1223)
Lu, Kaifeng , Jakate, Abhijeet , Finnegan, Michelle , Szegedi, Armin, Trugman, Joel M. , Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Cardiovascular Safety of Erenumab in Patients with Migraine and Aura (1209)
Tepper, Stewart J. , Xue, Fei , Olearczyk, J, Ashina, Messoud , Goadsby, Peter J. , Dodick, David W. , Zhang, Feng , Olearczyk, Jeffrey, Lima, Gabriel Paiva da Silva
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203)
Silberstein, Stephen D., Xue, Fei , Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Ubrogepant for the Acute Treatment of Migraine: Pooled Safety and Tolerability From ACHIEVE I and ACHIEVE II Phase 3 Studies (117)
Hutchinson, Susan , Treppendahl, Christina, Bennett, Nathan, Yu, Sung Yun , Guo, Hua , Trugman, Joel M. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available